Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;12(11):e201900115.
doi: 10.1002/jbio.201900115. Epub 2019 Aug 5.

Histogram analysis of en face scattering coefficient map predicts malignancy in human ovarian tissue

Affiliations

Histogram analysis of en face scattering coefficient map predicts malignancy in human ovarian tissue

Yifeng Zeng et al. J Biophotonics. 2019 Nov.

Abstract

Ovarian cancer is a heterogeneous disease at the molecular and histologic level. Optical coherence tomography (OCT) is able to map ovarian tissue optical properties and heterogeneity, which has been proposed as a feature to aid in diagnosis of ovarian cancer. In this manuscript, depth-resolved en face scattering maps of malignant ovaries, benign ovaries, and benign fallopian tubes obtained from 20 patients are provided to visualize the heterogeneity of ovarian tissues. Six features are extracted from histograms of scattering maps. All features are able to statistically distinguish benign from malignant ovaries. Two prediction models were constructed based on these features: a logistic regression model (LR) and a support vector machine (SVM). The optimal set of features is mean scattering coefficient and scattering map entropy. The LR achieved a sensitivity and specificity of 97.0% and 97.8%, and SVM demonstrated a sensitivity and specificity of 99.6% and 96.4%. Our initial results demonstrate the feasibility of using OCT as an "optical biopsy tool" for detecting the microscopic scattering changes associated with neoplasia in human ovarian tissue.

Keywords: cancer prediction; optical coherence tomography; ovarian cancer; scattering coefficient map.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Representative OCT images of benign and malignant ovary specimens. The ovarian surface epithelium is between the two red curves in the B-scan SS-OCT images. (A) representative B-scan image from a benign ovary and (B) corresponding H&E image. (C) representative B-scan image from a malignant ovary (high-grade serous carcinoma) and (D) corresponding H&E image. Inset: best-fit Beer’s law is used to calculate the scattering coefficient. OCT, optical coherence tomography
FIGURE 2
FIGURE 2
Photographs (A-C) of one benign ovary, one malignant ovary, and one benign fallopian tube, respectively. Scattering coefficient maps (D-F) of the scanned areas, identified as white boxes in Figure (A-C). The scale bar of 200 mm is shared by maps (D-F)
FIGURE 3
FIGURE 3
Histogram analysis of one representative malignant ovary (A) and one representative benign ovary (B). The six features for (A) are 4.0 mm−1(mean), 1.71(variance), 6.50(entropy), 0.77(skewness), 4.33(kurtosis), and 0.17(energy). The six features for (B) are 11.48mm−1(mean), 2.98(variance), 7.30(entropy), 0.22(skewness), 2.85(kurtosis), and 0.10(energy). Fitted Gaussian distribution is shown as red curves
FIGURE 4
FIGURE 4
Boxplot of the six features extracted from histogram analysis of scattering maps of malignant ovaries, benign ovaries, and benign fallopian tubes
FIGURE 5
FIGURE 5
Testing results of two optimal data sets ([mean, entropy] and [energy, skewness, entropy]) used to train two classification models. (A-B) show the ROC curves for the testing sets of logistic regression and (C-D) show the ROC curves of SVM model

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A, CA Cancer J. Clin. 2019, 69 (1), 7. - PubMed
    1. Nandy S, Mostafa A, Hagemann IS, Powell MA, Amidi E, Robinson K, Mutch DG, Siegel C, Zhu Q, Radiology 2019, 289(3), 740. - PMC - PubMed
    1. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL, CA Cancer J. Clin. 2018, 68(4), 284. - PMC - PubMed
    1. van Nagell JR Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, Kryscio RJ, Gynecol. Oncologia 2000, 77(3), 350. - PubMed
    1. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van’t Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, N. Engl. J. Med. 2002, 346(21), 1616. - PubMed

Publication types